Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on: January 04,2024

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on:January 04,2024

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for

Updated on: January 07,2024

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for

Updated on:January 07,2024

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing

Updated on: January 16,2024

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing

Updated on:January 16,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on: January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on:January 29,2024

Researchers identify effective drug combination against uveal melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Uveal mela

Updated on: June 08,2024

Researchers identify effective drug combination against uveal melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Uveal mela

Updated on:June 08,2024

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on: February 18,2024

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on:February 18,2024

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment

Updated on: January 22,2024

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment

Updated on:January 22,2024

Researchers find protein complex that regulates migration of neurons and neuroblastoma cancer cells

by University of BarcelonaGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.09.025During brain development, neurons have to migrate long distances through complex enviro

Updated on: February 23,2024

Researchers find protein complex that regulates migration of neurons and neuroblastoma cancer cells

by University of BarcelonaGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.09.025During brain development, neurons have to migrate long distances through complex enviro

Updated on:February 23,2024

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on: January 22,2024

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on:January 22,2024

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth

Updated on: May 23,2024

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth

Updated on:May 23,2024

Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer

by Josep Carreras Leukaemia Research InstituteNSUN7 epigenetic loss occurs in human primary HCC tumors in association with worse clinical outcome. (A) Percentage of NSUN7 methylation in the TCGA

Updated on: February 18,2024

Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer

by Josep Carreras Leukaemia Research InstituteNSUN7 epigenetic loss occurs in human primary HCC tumors in association with worse clinical outcome. (A) Percentage of NSUN7 methylation in the TCGA

Updated on:February 18,2024